Tehila Gershon

Small molecule inhibitor of Igf2bp1 represses Kras and a pro-oncogenic phenotype in cancer cells

V. Spiegelman, H. Barr, Khriesto A. Shurrush, 2021, RNA biology.

Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers.

V. Spiegelman, F. Oberman, Vikash Singh, 2023, European journal of medicinal chemistry.

AVJ16 inhibits the RNA binding protein IGF2BP1 in lung adenocarcinomas and prevents tumor growth in mice

V. Spiegelman, F. Oberman, N. Wallis, 2024, bioRxiv.